Age-dependent alteration of antioxidant defense system in hypertensive and type-2 diabetes patients

Journal of Diabetes and Metabolic Disorders

Volumn 14, Issue 1, 2015, Pages

  Okoduwa, Stanley I R ^a,b   Umar, Ismaila A ^b   Ibrahim, Sani ^b   Bello, Fatima ^b   Habila, Nathan ^b,c  

^a SIRONigeria Global Limited   (Nigeria)

^b AHMADU BELLO UNIVERSITY   (Nigeria)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Aging; Antioxidants; Diabetes and hypertension; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CATALASE; COPPER; GLUCOSE; GLUTATHIONE; IRON; MALONALDEHYDE; SELENIUM; SUPEROXIDE DISMUTASE; ZINC;

ADULT; AGE; AGED; AGING; ARTICLE; BLOOD LEVEL; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NIGERIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; SYSTOLIC BLOOD PRESSURE;

EID: 84989160066     PISSN: None     EISSN: 22516581     Source Type: Journal    
DOI: 10.1186/s40200-015-0164-z     Document Type: Article

References (50)

1. Cheng Y, Malik U, Chang S. The risk factors of diabetic nephropathy in Taiwan, including old age, hypertension and aspirin therapy. Int J Diabetes Dev Ctries. 2013;33 Suppl 2:128.
2. Kide S, Rangari A, Shiral R, Mane N, Yadav P, Ambulkar K, et al. Knowledge and awareness of diabetes amongst diabetes patients in Wardha region. Int J Diabetes Dev Ctries. 2014. doi:10.1007/s13410-013-0178-3.
3. Singh DK. Diabetic nephropathy: associated risk factors in renal deterioration. Int J Diabetes Dev Ctries. 2012;32 Suppl 3:113-5.
4. Pasupathi P, Bakthvathsalam G, Saravanan G, Latha R. Evaluation of oxidative stress and antioxidant status in patients with diabetes mellitus. J Appl Sci Res. 2009;5 Suppl 7:770-5.
5. Satyanarayana U, Chakrapani U. Free radicals and antioxidants. In: Biochemistry. Kolkata-India: Books and Allied (p) ltd; 2008. p. 655-61.
6. Vaziri ND. Causal link between oxidative stress, inflammation, and hypertension. Iran J kidney Dis. 2008;2:1-10. http://www.ijkd.org/index.php/ijkd/article/view/61. Accessed 27 Mar 2013.
7. Okoduwa SIR, Umar IA, Sani I, Bello F. Relationship of oxidative stress with type-2 diabetes and hypertension. J Diabetol. 2013;1:2. http://www.journalofdiabetology. org/Pages/Releases/FullTexts/TENTHISSUE/OA-2-JOD-12-019.aspx. Accessed 29 Mar 2013.
8. Das BS, Turnham DI, Painack J, Das DE, Satpathy R, Base TK. Increased plasma lipid peroxidation in riboflavin deficient malaria-inflected children. Ann J Clin Nutr. 1990;51:859-63.
9. Gil L, Siems W, Mazurek B, Gross J, Schroeder P, Voss P. Age associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radic Res. 2006;40:405-505.
10. Kumar KMP. Antioxidants for clinical use. Int J Diabetes Dev Ctries. 2012;32 Suppl 4:183-4.
11. Harman D. Free radical theory of aging: An update. Ann N Y Academy Science. 2006;1067:1-12.
12. United Nations. World Population Prospects The 2012 Revision: Key findings and advance tables Department of Economic and Social Affairs Population Division. 2013, Working Paper No. ESA/P/WP.227.
13. Deavall DG, Martin EA, Horner JM, Roberts R. Drug-Induce oxidative stress and toxicity. J Toxicol. 2012;10:1155-68.
14. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol. 1997;82 Suppl 2:291-529.
15. Halliwell B. Establishing the significance and optimal intake of dietary antioxidants: the biomarker concept. Nutr Rev. 1999;57:104-13.
16. Hanson K, Gratton ME, Bardeen CJ. Sunscreen enhancement of UV-induced reactive oxygen species in the skin. Free Radical Biological Medicine. 2006;11:6-11.
17. Drobiova H, Thomson M, Al-Qattan K, Peltonen-Shalaby R, Al-Aminand Z, Ali M. Garlic increases antioxidant levels in diabetic and hypertensive rats determined by a modified peroxidase method. 2009; eCAM Advance Access: online: http://dx.doi.org/10.1093/ecam/nep011
18. Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes. 2008;57 Suppl 6:1446-54.
19. Potenza MA, Gagliardi S, Nacci C, Carratu MR, Montagnani M. Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Current Med Chem. 2009;16:94-112.
20. JNC7: Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Rockville, Md. National Heart, Lung, and Blood Institute, US Department of Health and Human Services, National Institutes of Health Publication. 2004; No. 04-5230.
21. ADA: American Diabetes Association. Diagnosis and classification of diabetes mellitus. Position statement. Diabetes Care. 2014;37 Suppl 1:S81-90.
22. WMA: World Medical Association declaration of Helsinki. Ethical principles for medical research involving human subjects. 52nd WMA general assembly, Edinburgh. 2000, 17C.
23. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Ann Biochem. 1969;27:502-22.
24. Martins JP, Dailey M, Sugarman E. Negative and positive assays of superoxide dismutase based on hematoxylin autoxidation. Arch Biochem. 1987;255:329-36.
25. Aebi HE. Catalase. In: Bergmeyer HU, editor. Method of enzymatic analysis, vol. 3. Weinheim: VCH Verlag; 1987. p. 273-8.
26. Omaye ST, Turbull TP, Sauberchich HC. Selected methods for determination of ascorbic acid in cells, tissues and fluids. Methods Enzymol. 1979;6:3-11.
27. Desai ID. Vitamin E, methods for animal tissues. Methods Enzymol. 1984;105:138-43.
28. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen receptor. Ann Clin Biochem. 1969;6:24-7.
29. Perrotta G. Iron and iron-binding capacity. In: Kaplan A, editor. Clinical chemistry. St Louis, Toronto, Princeton: The C.V. Mosby Co; 1984. p. 1063-5.
30. Burtis A. Serum Zinc and Copper. Textbook of clinical chemistry. 3rd ed. American Association Clinical Chemists. 1999. P. 336-356.
31. Mahreen R, Mohsin M, Nasreen Z, Siraj M, Ishaq M. Significantly increased levels of serum malonaldehyde in type 2 diabetics with myocardial infarction. Int J Diabetes Dev Ctries. 2010;30:49-51.
32. Ozdemir G, Ozden M, Maral H, Kuskay S, Cetinalp P, Tarkun I. Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and with-out microalbuminuria. Ann Clin Biochem. 2005;42:99-104.
33. Ohtsuki T, Malasumoto M, Suzuki K, Taniguchi N, Kadanada T. Mitochondrial lipid peroxidation and superoxide dismutase in rat hypertensive target organs. Am J Physiol. 1995;268:1418-21.
34. Kumawat M, Pahwa MB, Gahlaut VS, Singh N. Status of antioxidant enzymes and lipid peroxidation in type 2 diabetes mellitus with microvascular Complications. Open Endocrinol J. 2009;3:13-6.
35. Salem M, Kholoussi S, Kholoussi N, Fawzy R. Malondialdehyde and trace element levels in patients with type 2 diabetes mellitus. Arch Hellenic Med. 2011;28 Suppl 1:83-8.
36. Salo DC, Pacifici RE, Lin SW, Giulivi C, Davies KJ. Superoxide dismutase undergo proteolysis and fragmentation following oxidation modification and inactivation. J Bio Chem. 1990;15(265 Suppl 20):11919-27.
37. Ceballos I, Delebar JM, Nicole A. Expression of transfected human Cu-Zn SOD in mouse L cells and NS20Y neuroblastoma cells induces enhancement of glutathione peroxidase activity. Biochem Biophy Acta. 1998;949:58-64.
38. Gonenc A, Erten D, Aslan S. Lipid peroxidation and antioxidant status in blood and tissue of malignant breast tumor and benign breast disease. Cell Biol Int. 2006;30:376-80.
39. Yeh CC, Hou MF, Tsai SM. Superoxide anion radical, lipid peroxides and antioxidant status in the blood of patients with breast cancer. Clin Chim Acta. 2005;361:104-11.
40. Kumar NL, Deepthi J, Rao YN, Deedi MK. Study of lipid profile, serum magnesium and blood glucose in hypertension. Biol Med. 2010;2 Suppl 1:6-16.
41. Sozmen EY, Sozmen B, Delen Y, Onat T. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control. Arch Med Res. 2001;32:283-7.
42. Farombi EO, Olowg B, Emerole GO. Effect of three structurally related antimalarial drugs on liver microsomal components and lipid peroxidation in rats comp. Biochem Physiol. 2000;126:217-24.
43. Ruiz C, Algeria A, Barbera R, Farre R, Lagarda MJ. Selenium, zinc and copper in plasma of patients with type 1 diabetes mellitus in different metabolic control states. J Trace Elem Med Biol. 1998;12:91-5.
44. Karatas F, Halifeoglu I, Karatepe M, Konar V, Canatan H, Colak R. Evaluation of changes in the level of serum selenium, malondiadehyde and antioxidant vitamins (A, E, C) in Diabetic patients. Fusabil. 2006;20 Suppl 6:391-5.
45. Joshi U, Raut PD, Agrawal SK, Patra PK, Maheshwari BK, Apurb M, et al. Evaluation of serum selenium level in patients with uncomplicated diabetes mellitus, Raipur. India J Clin Diagn Res. 2011;5:70-3.
46. Diplock AT. Antioxidant nutrients and disease prevention: an overview. Am J Clin Nutr. 1991;53:189S-93.
47. Ahmad M, Khan MA, Khan AS. Oxidative stress and level of iron indices in coronary heart disease patients. J Ayub Med Coll Abbottabad. 2009;21:2-5.
48. Vural H, Uzun K, Uz E. Concentrations of copper, zinc and various elements in serum of patients with bronchial asthma. J Trace Elem Med Biol. 2000;14 Suppl 2:88-91.
49. Lin J. The association between copper ions and peroxidative reaction in diabetic cataract. Nippon Ganka Gakkai Zasshi. 1996;100 Suppl 9:672-9.
50. Mimic OJ, Simic T, Djukanovic Z. Red blood cell glutathione peroxidase and superoxide dismutase activity in different status of chronic renal failure. Clin Nephrol. 1995;44:44-8.